MktsMarkets

Aurinia Pharmaceuticals Inc
NASDAQ: AUPHKey statistics
AUPH News
Stories mentioning AUPH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 77,705 | 77,114 | 73,468 | 70,008 | 62,465 | 59,867 | 67,771 | 57,192 |
| Cost of Goods Sold | 6,505 | 8,799 | 8,177 | 7,115 | 8,574 | 5,552 | 6,035 | 8,909 |
| Gross Profit | 71,200 | 68,315 | 65,291 | 62,893 | 53,891 | 54,315 | 61,736 | 48,283 |
| Operating Expenses | ||||||||
| Research & Development | 7,470 | 10,895 | 8,435 | 7,432 | 5,743 | 8,107 | 3,047 | 4,080 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 43,875 | 43,723 | 49,925 | 40,618 | 61,536 | 56,023 | 58,705 | |
| Operating Income (Loss) | 41,422 | 33,239 | 29,745 | 20,083 | 21,847 | (1,669) | 11,748 | (1,513) |
| Interest Income | 3,515 | 3,498 | 3,316 | 3,190 | 3,569 | 3,988 | 4,267 | 4,189 |
| Interest Expense | 1,198 | |||||||
| Other Expense | ||||||||
| Pretax Income | 43,925 | 35,690 | 31,962 | 22,156 | 24,349 | 1,173 | 14,807 | 1,478 |
| Tax Provision | 9,570 | (175,104) | 411.00 | 643.00 | 1,005 | (256.00) | 457.00 | 756.00 |
| Net Income (Loss) | 34,355 | 210,794 | 31,551 | 21,513 | 23,344 | 1,429 | 14,350 | 722.00 |
| Earnings Per Share (Basic) | 0.26 | 1.60 | 0.24 | 0.16 | 0.17 | 0.01 | 0.10 | 0.01 |
| Earnings Per Share (Diluted) | 0.25 | 1.53 | 0.23 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 |
| Weighted Average Shares Outstanding (Basic) | 132,375 | 134,367 | 131,808 | 134,873 | 138,917 | 143,057 | 143,051 | 143,327 |
| Weighted Average Shares Outstanding (Diluted) | 137,639 | 138,700 | 136,008 | 137,526 | 143,199 | 146,194 | 145,651 | 144,110 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AUPH
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol AUPH. It last traded at $15.13 (Nov 18, 2026, 4:00 PM ET), down 1.8% on the day. That gives Aurinia Pharmaceuticals a market capitalisation of $2.0B and a price-to-earnings ratio of 6.5.
Over the past 52 weeks AUPH has traded between $13.52 and $19.25.
Revenue for the quarter ended Mar 31, 2026 was $77.7M; net income $34.4M. Revenue was up 24.4% from $62.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $77.7M | $34.4M | 44.2% |
| Dec 31, 2025 | $77.1M | $210.8M | 273.4% |
| Sep 30, 2025 | $73.5M | $31.6M | 42.9% |
| Jun 30, 2025 | $70.0M | $21.5M | 30.7% |
From Aurinia Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…